Literature DB >> 16782965

NAION and treatment of erectile dysfunction: reply from Pfizer.

R E Sobel, J C Cappelleri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16782965      PMCID： PMC1857126          DOI： 10.1136/bjo.2006.094375

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  3 in total

Review 1.  Phosphodiesterase 5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NAION): coincidence or causality?

Authors:  Dimitris Hatzichristou
Journal:  J Sex Med       Date:  2005-11       Impact factor: 3.802

2.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

3.  Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction.

Authors:  G McGwin; M S Vaphiades; T A Hall; C Owsley
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638
  3 in total
  2 in total

1.  Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases.

Authors:  Alberto Galvez-Ruiz; Nawal Arishi
Journal:  Saudi J Ophthalmol       Date:  2013-07-22

Review 2.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.